Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 59 articles: HTML format Text format

Single Articles

January 2012
1. CLIFFORD GM , Lise M, Franceschi S, Egger M, et al
   Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection.
   Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. TANIZAKI J , Okamoto I, Takezawa K, Sakai K, et al
   Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cells.
   Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BONI C , Tiseo M, Boni L, Baldini E, et al
   Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
   Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. MCCORMACK V , Peto J, Byrnes G, Straif K, et al
   Estimating the asbestos-related lung cancer burden from mesothelioma mortality.
   Br J Cancer. 2012 Jan 10. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. ARAI E , Nishida Y, Wasa J, Urakawa H, et al
   Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.
   Br J Cancer. 2011;105:1839-49.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. PARKIN DM
   2. Tobacco-attributable cancer burden in the UK in 2010.
   Br J Cancer. 2011;105 Suppl 2:S6-S13.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
7. MEMON AA , Weber B, Winterdahl M, Jakobsen S, et al
   PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer.
   Br J Cancer. 2011 Nov 17. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. FIDLER MJ , Morrison LE, Basu S, Buckingham L, et al
   PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy.
   Br J Cancer. 2011 Nov 17. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LARZABAL L , Nguewa PA, Pio R, Blanco D, et al
   Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology.
   Br J Cancer. 2011;105:1608-14.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
10. SHIMOKAWA H , Uramoto H, Tanaka F
    Comment on 'Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab'.
    Br J Cancer. 2011;105:1465-6.
    PubMed     Text format     Related articles   
    
    
    
    
11. FUJISAKA Y , Sugiyama T, Saito H, Nagase S, et al
    Randomised, phase III trial of epoetin-beta to treat chemotherapy-induced anaemia according to the EU regulation.
    Br J Cancer. 2011;105:1267-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. FUKUDA H , Mochizuki S, Abe H, Okano HJ, et al
    Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production.
    Br J Cancer. 2011 Oct 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. LECHARPENTIER A , Vielh P, Perez-Moreno P, Planchard D, et al
    Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer.
    Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
14. CARPAGNANO GE , Koutelou A, Natalicchio MI, Martinelli D, et al
    HPV in exhaled breath condensate of lung cancer patients.
    Br J Cancer. 2011 Sep 27. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. COLIN S , Guilmain W, Creoff E, Schneider C, et al
    A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth.
    Br J Cancer. 2011;105:1002-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LECAER H , Barlesi F, Corre R, Jullian H, et al
    A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the
    Br J Cancer. 2011 Sep 20. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. HORIIKE A , Kudo K, Miyauchi E, Ohyanagi F, et al
    Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer.
    Br J Cancer. 2011 Sep 13. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. DALTON SO , Frederiksen BL, Jacobsen E, Steding-Jessen M, et al
    Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008.
    Br J Cancer. 2011 Sep 6. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
19. MITA AC , Papadopoulos K, de Jonge MJ, Schwartz G, et al
    Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer.
    Br J Cancer. 2011 Aug 30. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. JACK RH , Davies EA, Moller H
    Lung cancer incidence and survival in different ethnic groups in South East England.
    Br J Cancer. 2011 Aug 23. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SCHULTZ H , Marwitz S, Baron-Luhr B, Zissel G, et al
    Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung.
    Br J Cancer. 2011;105:673-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. MCELVENNY DM , Hurley MA, Lenters V, Heederik D, et al
    Lung cancer mortality in a cohort of UK cotton workers: an extended follow-up.
    Br J Cancer. 2011 Aug 16. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. TANIZAKI J , Okamoto I, Sakai K, Nakagawa K, et al
    Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification.
    Br J Cancer. 2011 Aug 16. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. ARRIOLA E , Canadas I, Arumi-Uria M, Domine M, et al
    MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines.
    Br J Cancer. 2011 Aug 16. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. RICH AL , Tata LJ, Free CM, Stanley RA, et al
    How do patient and hospital features influence outcomes in small-cell lung cancer in England?
    Br J Cancer. 2011 Aug 9. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
26. MORGILLO F , Cascone T, D'Aiuto E, Martinelli E, et al
    Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors.
    Br J Cancer. 2011 Jul 12. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
27. XIANG R , Liao D, Cheng T, Zhou H, et al
    Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer.
    Br J Cancer. 2011;104:1931.
    PubMed     Text format     Related articles   
    
    
    
    
28. PALLIS AG , Fennell DA, Szutowicz E, Leighl NB, et al
    Biomarkers of clinical benefit from anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer.
    Br J Cancer. 2011 Jun 7. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KOSHIOL J , Gulley ML, Zhao Y, Rubagotti M, et al
    Epstein-Barr virus microRNAs and lung cancer.
    Br J Cancer. 2011 Jun 7. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. GRIGORIEVA EV , Prudnikova TY, Domanitskaya NV, Mostovich LA, et al
    D-Glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.
    Br J Cancer. 2011 Jun 7. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
31. GAO W , Gulliford M, Higginson IJ
    Prescription patterns of analgesics in the last 3 months of life: a retrospective analysis of 10202 lung cancer patients.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
32. JUBB AM , Cesario A, Ferguson M, Congedo MT, et al
    Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
33. VINCENT EE , Elder DJ, Thomas EC, Phillips L, et al
    Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. TAKEZAWA K , Okamoto I, Okamoto W, Takeda M, et al
    Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. XIANG R , Liao D, Cheng T, Zhou H, et al
    Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
36. HALL JS , Leong HS, Armenoult LS, Newton GE, et al
    Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples.
    Br J Cancer. 2011;104:971-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. FIORENTINO F , Vasilakis C, Treasure T
    Clinical reports of pulmonary metastasectomy for colorectal cancer: a citation network analysis.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
38. TASAKI M , Shimada K, Kimura H, Tsujikawa K, et al
    ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. PETO J
    That lung cancer incidence falls in ex-smokers: misconceptions 2.
    Br J Cancer. 2011;104:389.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
40. GUILMAIN W , Colin S, Legrand E, Vannier JP, et al
    CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. BASU B , Olmos D, de Bono JS
    Targeting IGF-1R: throwing out the baby with the bathwater?
    Br J Cancer. 2011;104:1-3.
    PubMed     Text format     Related articles   
    
    
    
    
42. GUALBERTO A , Hixon ML, Karp DD, Li D, et al
    Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.
    Br J Cancer. 2011;104:68-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
43. PAPADAKI C , Tsaroucha E, Kaklamanis L, Lagoudaki E, et al
    Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
44. ROTUNNO M , Zhao Y, Bergen AW, Koshiol J, et al
    Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. TSE LA , Yu IS, Au JS, Qiu H, et al
    Silica dust, diesel exhaust, and painting work are the significant occupational risk factors for lung cancer in nonsmoking Chinese men.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LOEBINGER MR , Sage EK, Davies D, Janes SM, et al
    TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population.
    Br J Cancer. 2010;103:1692-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. LAWSON MH , Cummings NM, Rassl DM, Vowler SL, et al
    Bcl-2 and beta(1)-integrin predict survival in a tissue microarray of small cell lung cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
48. OSHITA F , Ohe M, Honda T, Murakami S, et al
    Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. MARTINEZ VD , Buys TP, Adonis M, Benitez H, et al
    Arsenic-related DNA copy-number alterations in lung squamous cell carcinomas.
    Br J Cancer. 2010;103:1277-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
50. LIN PY , Yu SL, Yang PC
    MicroRNA in lung cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. FARLOW EC , Vercillo MS, Coon JS, Basu S, et al
    A multi-analyte serum test for the detection of non-small cell lung cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. WONG KY , Seow A, Koh WP, Shankar A, et al
    Smoking cessation and lung cancer risk in an Asian population: Findings from the Singapore Chinese Health Study.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
53. KORNER A , Mudduluru G, Manegold C, Allgayer H, et al
    Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. TENG Y , Ren MQ, Cheney R, Sharma S, et al
    Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. PENG G , Hakim M, Broza YY, Billan S, et al
    Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.
    Br J Cancer. 2010;103:542-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. SCHMID K , Bago-Horvath Z, Berger W, Haitel A, et al
    Dual inhibition of EGFR and mTOR pathways in small cell lung cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
57. LEE KM , Chapman RS, Shen M, Lubin JH, et al
    Differential effects of smoking on lung cancer mortality before and after household stove improvement in Xuanwei, China.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. DZI ECEDIL GIEL P , Owczarek T, Pla Zgrave Uk E, Gomulkiewicz A, et al
    Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. LUNT SJ , Cawthorne C, Ali M, Telfer BA, et al
    The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.
    Br J Cancer. 2010;103:201-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: